Skip to main content
. 2022 Mar 22;66(4):e02181-21. doi: 10.1128/aac.02181-21

FIG 6.

FIG 6

(A–D) Pharmacodynamics of tobramycin at 0.67, 2, and 3.33 mg/kg q8h i.v. as assessed using the bacterial burden in the CSF of rabbits infected with P. aeruginosa ATCC 27853. Treatment was initiated 6 h postinoculation at time = 0. The solid black lines in each panel are LOWESS regression lines fitted to the pooled data from each cohort of rabbits. There was no obvious dose exposure response relationship.